Transcription of THE JAPANESE PHARMACOPOEIA - NIHS
{{id}} {{{paragraph}}}
Example: bachelor of science
THE JAPANESE PHARMACOPOEIA - NIHS
JP XVIITHE JAPANESE PHARMACOPOEIASEVENTEENTH EDITIONO fficial from April 1, 2016 English VersionTHE MINISTRY OF HEALTH, LABOUR AND WELFAREN otice: ThisEnglish Versionof the JAPANESE PHARMACOPOEIA is publishedfor the convenience of users unfamiliar with the JAPANESE language. Whenand if any discrepancy arises between the JAPANESE original and its Englishtranslation, the former is Ministry of Health, Labour andWelfare Ministerial Notification No. 64 Pursuant to Paragraph 1, Article 41 of theLaw on Securing Quality, Efficacy andSafety of Products including Pharmaceuticals and Medical Devices (Law No. 145,1960), the JAPANESE PHARMACOPOEIA (Ministerial Notification No. 65, 2011), whichhas been established as follows*, shall be applied on April 1, 2016. However, in thecase of drugs which are listed in the PHARMACOPOEIA (hereinafter referred to as ``previ-ous PHARMACOPOEIA '') [limited to those listed in the JAPANESE PHARMACOPOEIA whosestandards are changed in accordance with this notification (hereinafter referred to as``new PHARMACOPOEIA '')] and have been approved as of April 1, 2016 as prescribedunder Paragraph 1, Article 14 of the same law [including drugs the Minister ofHealth, Labour and Welfare specifies (the Ministry of Health and Welfare MinisterialNotification No.)]
JP XVII THE JAPANESE PHARMACOPOEIA SEVENTEENTH EDITION Official from April 1, 2016 English Version THE MINISTRY OF HEALTH, LABOUR AND WELFARE
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: